No, haven't traded Epitan / Clinuvel since 2006! It's been on my watchlist though and I have seen it turn into a ten-bagger from $4.50 to $45 over the last few years. I believe the next major phase could be a take-over once their lead drug becomes market ready. Keep an eye out for news on collaboration with a large pharma (I'M NOT SAYING THIS WILL HAPPEN). CUV really is the little engine that could...
Price targets, page-42
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.69 |
Change
0.060(0.44%) |
Mkt cap ! $685.3M | |||
| Open | High | Low | Value | Volume |
| $13.63 | $13.94 | $13.59 | $674.1K | 49.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1200 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.75 | 179 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |